Insider Trading › BHC › Insiders
Bausch Health Companies Inc.
BHC·NYSE·
Canada·Insider activity
Canada·Insider activity$6.15
+0.13 (+2.16%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
BHC
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
BHCS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, BHC insiders filed 0 purchases ($0) and 2 sales ($392K) on the open market, by 2 insiders. Newest filing Aug 20, 2026 (1 month ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by BHC insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$392KSales · 180 days
79Open-market transactions on record
2Insiders filing · 180 days
Purchases (code P) and sales (code S) of BHC common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
79 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Lenar Aimee J.President, US Pharma | Sale | −36.8K | $7.03 | $259K | 334.9Kdirect | Aug 19, 2026 | Aug 20, 2026 | Form 4 ↗ |
| Lee Frank D.Director | Sale | −24.5K | $5.43 | $133K | 49.3Kdirect | May 19, 2026 | May 20, 2026 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −4,420 | $5.77 | $26K | 616.8Kdirect | Mar 3, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −6,856 | $5.78 | $40K | 776.1Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −8,388 | $5.95 | $50K | 809.3Kdirect | Feb 27, 2026 | Feb 27, 2026 | Form 4 ↗ |
| PAULSON & CO. INC.10% owner | Purchase | +2.5M | $6.25 | $15.6M | 73.3Mindirect | Nov 25, 2025 | Nov 28, 2025 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −13.4K | $7.31 | $98K | 499.6Kdirect | Sep 8, 2025 | Sep 8, 2025 | Form 4 ↗ |
| Lee Frank D.Director | Sale | −15.9K | $7.66 | $122K | 73.8Kdirect | Aug 21, 2025 | Aug 22, 2025 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +34.7M | n/c | — | 70.8Mindirect | Aug 14, 2025 | Aug 14, 2025 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +86.4K | $7.06 | $610K | 36.0Mindirect | Aug 13, 2025 | Aug 13, 2025 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +1.2M | $6.88 | $8.0M | 35.9Mindirect | Aug 12, 2025 | Aug 13, 2025 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +2.0M | $6.35 | $12.7M | 34.8Mindirect | Aug 11, 2025 | Aug 13, 2025 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +3.6M | $5.94 | $21.2M | 32.8Mindirect | Jun 13, 2025 | Jun 17, 2025 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +1.0M | $5.47 | $5.5M | 29.2Mindirect | Jun 12, 2025 | Jun 12, 2025 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +1.0M | $5.24 | $5.4M | 28.2Mindirect | Jun 11, 2025 | Jun 12, 2025 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +754.1K | $5.05 | $3.8M | 27.2Mindirect | Jun 10, 2025 | Jun 12, 2025 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −440 | $8.35 | $4K | 433.1Kdirect | Dec 2, 2024 | Dec 3, 2024 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −13.4K | $6.21 | $83K | 435.2Kdirect | Sep 6, 2024 | Sep 9, 2024 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −133 | $9.80 | $1K | 499.9Kdirect | Mar 4, 2024 | Mar 4, 2024 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −1,561 | $9.80 | $15K | 500.0Kdirect | Mar 4, 2024 | Mar 4, 2024 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −199 | $9.80 | $2K | 501.6Kdirect | Mar 4, 2024 | Mar 4, 2024 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −4,420 | $9.80 | $43K | 501.8Kdirect | Mar 4, 2024 | Mar 4, 2024 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −220 | $7.38 | $2K | 382.9Kdirect | Dec 5, 2023 | Dec 5, 2023 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −43 | $7.61 | $327 | 384.8Kdirect | Nov 6, 2023 | Nov 6, 2023 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −6,685 | $8.28 | $55K | 385.2Kdirect | Sep 6, 2023 | Sep 6, 2023 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale Amended | −495 | $9.17 | $5K | 443.2Kdirect | Mar 6, 2023 | Mar 7, 2023 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale Amended | −780 | $9.34 | $7K | 443.7Kdirect | Mar 3, 2023 | Mar 7, 2023 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −292 | $9.32 | $3K | 359.2Kdirect | Feb 28, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Spurr RobertU.S. President-Pharma Business | Sale | −1,595 | $22.19 | $35K | 90.5Kdirect | Apr 14, 2022 | Apr 15, 2022 | Form 4 ↗ |
| Spurr RobertU.S. President-Pharma Business | Sale | −4,846 | $22.20 | $108K | 92.1Kdirect | Mar 15, 2022 | Mar 16, 2022 | Form 4 ↗ |
| Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l | Sale | −3,889 | $21.76 | $85K | 93.1Kdirect | Mar 8, 2022 | Mar 10, 2022 | Form 4 ↗ |
| Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l | Sale | −11.1K | $23.37 | $259K | 101.1Kdirect | Mar 2, 2022 | Mar 4, 2022 | Form 4 ↗ |
| Spurr RobertU.S. President-Pharma Business | Sale | −1,595 | $23.37 | $37K | 65.4Kdirect | Mar 2, 2022 | Mar 4, 2022 | Form 4 ↗ |
| Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l | Sale | −6,338 | $23.82 | $151K | 112.2Kdirect | Mar 1, 2022 | Mar 2, 2022 | Form 4 ↗ |
| Spurr RobertU.S. President-Pharma Business | Sale | −3,251 | $25.02 | $81K | 60.3Kdirect | Feb 15, 2022 | Feb 17, 2022 | Form 4 ↗ |
| Spurr RobertU.S. President-Pharma Business | Sale | −3,251 | $26.63 | $87K | 63.5Kdirect | Jan 18, 2022 | Jan 20, 2022 | Form 4 ↗ |
| Miller Steven DDirector | Purchase | +10.0K | $24.17 | $242K | 10.0Kindirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| Miller Steven DDirector | Purchase | +50.0K | $24.24 | $1.2M | 60.8Kdirect | Nov 30, 2021 | Dec 2, 2021 | Form 4 ↗ |
| VON ESCHENBACH ANDREW C.Director | Purchase | +1,400 | $25.94 | $36K | 38.6Kdirect | Aug 5, 2021 | Aug 9, 2021 | Form 4 ↗ |
| DE SCHUTTER RICHARD UDirector | Purchase | +10.0K | $25.01 | $250K | 317.1Kdirect | Aug 4, 2021 | Aug 6, 2021 | Form 4 ↗ |
| Eldessouky SamEVP & Chief Financial Officer | Sale | −17.0K | $31.68 | $539K | 116.9Kdirect | Jun 11, 2021 | Jun 15, 2021 | Form 4 ↗ |
| ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL | Sale | −121.2K | $31.83 | $3.9M | 166.8Kdirect | Jun 2, 2021 | Jun 4, 2021 | Form 4 ↗ |
| WECHSLER AMY BDirector | Sale | −11.0K | $31.79 | $351K | 98.3Kdirect | May 26, 2021 | May 28, 2021 | Form 4 ↗ |
| Humphries William D.President, Ortho-Dermatologics | Sale | −114.1K | $19.87 | $2.3M | 235.0Kdirect | Dec 4, 2020 | Dec 8, 2020 | Form 4 ↗ |
| Humphries William D.President, Ortho-Dermatologics | Sale | −13.7K | $19.63 | $268K | 235.0Kdirect | Nov 27, 2020 | Nov 30, 2020 | Form 4 ↗ |
| Humphries William D.President, Ortho-Dermatologics | Sale | −21.7K | $19.63 | $425K | 235.0Kdirect | Nov 24, 2020 | Nov 30, 2020 | Form 4 ↗ |
| Humphries William D.President, Ortho-Dermatologics | Sale | −1,483 | $19.63 | $29K | 235.0Kdirect | Nov 23, 2020 | Nov 30, 2020 | Form 4 ↗ |
| Humphries William D.President, Ortho-Dermatologics | Sale | −5,667 | $16.17 | $92K | 235.0Kdirect | Sep 8, 2020 | Sep 10, 2020 | Form 4 ↗ |
| ValueAct Holdings II, L.P.Director | Purchase | +948.4K | $19.24 | $18.2M | 17.9Mindirect | Jun 5, 2020 | Jun 9, 2020 | Form 4 ↗ |
| ValueAct Holdings II, L.P.Director | Sale | −948.4K | $19.24 | $18.2M | 0indirect | Jun 5, 2020 | Jun 9, 2020 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +585.1K | $15.92 | $9.3M | 25.8Mindirect | May 14, 2020 | May 14, 2020 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +624.9K | $15.87 | $9.9M | 25.3Mindirect | May 14, 2020 | May 14, 2020 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +70.0K | $15.65 | $1.1M | 24.6Mindirect | May 14, 2020 | May 14, 2020 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +348.9K | $15.85 | $5.5M | 24.6Mindirect | May 14, 2020 | May 14, 2020 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +645.8K | $16.70 | $10.8M | 24.2Mindirect | May 13, 2020 | May 14, 2020 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +80.3K | $16.58 | $1.3M | 23.6Mindirect | May 13, 2020 | May 14, 2020 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +603.9K | $16.32 | $9.9M | 23.5Mindirect | May 13, 2020 | May 14, 2020 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +799.9K | $17.24 | $13.8M | 22.9Mindirect | May 12, 2020 | May 14, 2020 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +678.4K | $17.47 | $11.9M | 22.1Mindirect | May 12, 2020 | May 14, 2020 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +374.8K | $17.33 | $6.5M | 21.4Mindirect | May 12, 2020 | May 14, 2020 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +162.9K | $17.50 | $2.9M | 21.0Mindirect | May 12, 2020 | May 14, 2020 | Form 4 ↗ |
| Paulson JohnDirector | Purchase | +25.0K | $17.30 | $433K | 20.9Mindirect | May 12, 2020 | May 14, 2020 | Form 4 ↗ |
| Ross Thomas W. Sr.Director | Purchase | +2,500 | $15.54 | $39K | 79.2Kdirect | Mar 12, 2020 | Mar 16, 2020 | Form 4 ↗ |
| ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL | Purchase | +4,390 | $18.25 | $80K | 91.6Kdirect | Mar 10, 2020 | Mar 11, 2020 | Form 4 ↗ |
| VON ESCHENBACH ANDREW C.Director | Purchase | +1,100 | $18.18 | $20K | 18.6Kdirect | Mar 10, 2020 | Mar 11, 2020 | Form 4 ↗ |
| DE SCHUTTER RICHARD UDirector | Purchase | +3,800 | $18.26 | $69K | 13.8Kindirect | Mar 10, 2020 | Mar 11, 2020 | Form 4 ↗ |
| DE SCHUTTER RICHARD UDirector | Purchase | +5,000 | $23.08 | $115K | 279.3Kdirect | Mar 3, 2020 | Mar 11, 2020 | Form 4 ↗ |
| PAPA JOSEPH CCHAIRMAN & CEO · Director | Purchase | +30.0K | $23.31 | $699K | 839.6Kdirect | Sep 13, 2019 | Sep 13, 2019 | Form 4 ↗ |
| McKenna Mark C.President, Salix | Sale | −10.8K | $21.83 | $235K | 20.8Kdirect | Aug 19, 2019 | Aug 21, 2019 | Form 4 ↗ |
| Humphries William D.President, Ortho-Dermatologics | Purchase | +30.7K | $21.18 | $650K | 147.7Kdirect | Aug 16, 2019 | Aug 20, 2019 | Form 4 ↗ |
| ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL | Sale | −3,418 | $22.45 | $77K | 50.5Kdirect | Aug 12, 2019 | Aug 13, 2019 | Form 4 ↗ |
| ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL | Sale | −3,968 | $24.81 | $98K | 61.7Kdirect | Jul 11, 2019 | Jul 15, 2019 | Form 4 ↗ |
| PAPA JOSEPH CCHAIRMAN & CEO · Director | Purchase | +30.0K | $23.67 | $710K | 717.1Kdirect | Feb 28, 2019 | Feb 28, 2019 | Form 4 ↗ |
| APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l | Purchase | +25.4K | $22.96 | $584K | 128.9Kdirect | Dec 14, 2018 | Dec 18, 2018 | Form 4 ↗ |
| ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL | Sale | −4,542 | $25.50 | $116K | 51.5Kdirect | Oct 16, 2018 | Oct 17, 2018 | Form 4 ↗ |
| ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL | Sale | −15.4K | $24.83 | $382K | 56.0Kdirect | Oct 15, 2018 | Oct 17, 2018 | Form 4 ↗ |
| Herendeen PaulEVP and CFO | Purchase | +10.0K | $22.61 | $226K | 216.9Kdirect | Sep 14, 2018 | Sep 17, 2018 | Form 4 ↗ |
| PAPA JOSEPH CCHAIRMAN & CEO · Director | Purchase | +30.0K | $22.32 | $670K | 657.1Kdirect | Sep 14, 2018 | Sep 17, 2018 | Form 4 ↗ |
| DE SCHUTTER RICHARD UDirector | Purchase | +125.0K | $23.96 | $3.0M | 259.7Kdirect | Sep 13, 2018 | Sep 17, 2018 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →